OTC News
Most Popular OTC Story
Daiichi aims for 60 percent growth
Daiichi Sankyo says it's ready for it's close-up. The company got FDA approval last week for a combo remedy for hypertension, Azor, and now it's meeting with its Congressman to talk about adding new Read more...
Latest Headlines
- January 10, 2012
- December 14, 2011
- December 8, 2011
- November 15, 2011
- November 3, 2011
- October 4, 2011
- September 29, 2011
- September 29, 2011
- September 16, 2011
- August 23, 2011
- August 4, 2011
- August 1, 2011
- June 14, 2011
- April 8, 2011
- March 25, 2011
- March 24, 2011
- January 26, 2011
- November 23, 2010
- August 31, 2010
- July 8, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
